TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 17, 2026 · Chief Legal Officer and GC REED ELIZABETH E sold 37.50K shares at $62.34/share ($2.3M); exercised options for 75K shares

Chief Legal Officer and GC REED ELIZABETH E sold 37.50K shares at $62.34/share ($2.3M); exercised options for 75K shares

xslF345X06/form4-09182026_010948.xml

xslF345X06/form4-09182026_010948.xmlSEC.gov

Graphics and non-inline formats (not embedded below).